A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease
ACS Chemical Neuroscience · 27.10.2026
DOI: 10.1021/acschemneuro.6c00379 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 27.10.2026. Verfasst von Nitika Sindhu und 3 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Department of Science and Technology.
Themen: Demenz
Abstract (Originalsprache)
Mitochondrial dysfunction is an early pathological aspect of Alzheimer’s disease (AD) that promotes oxidative stress, leading to amyloid β-plaque formation and neurofibrillary tangles. Thus, targeted mitochondrial therapy and mitochondrial transplantation have emerged as promising therapeutic strategies. However, excessive oxidative stress and neuroinflammation in the microenvironments of the AD brain limit the functional and stable integration of transplanted mitochondria. In this study, we have engineered a Mito-CoQ10-TPP hybrid nanocarrier by conjugating triphenylphosphonium (TPP), a lipophilic cation, with Coenzyme Q10 (CoQ10) and localized it to mitochondria isolated from healthy cortical brain cells. This nanocarrier hybrid was administered via a single intravenous (IV) dose to streptozotocin (STZ)-induced AD in mice. A comprehensive evaluation of mitochondrial function, amyloid burden, neuroinflammation, apoptosis, biogenesis, and behavior revealed that CoQ10-TPP conjugation significantly improved the mitochondrial transplantation efficacy in the amelioration of AD. Thus, conjugating the antioxidant CoQ10 with mitochondrial transplantation significantly improved the overall therapeutic efficacy, indicating the use of the Mito-CoQ10-TPP hybrid nanocarrier as a promising therapeutic strategy.
Förderung
- Department of Science and Technology
Zitieren
APA
Sindhu, N., Jain, S., Sharma, S., & Paliwal, S. (2026). A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.6c00379
Vancouver
Sindhu N, Jain S, Sharma S, Paliwal S. A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease. ACS Chemical Neuroscience. 2026. doi:10.1021/acschemneuro.6c00379
BibTeX
@article{Sindhu2026,
author = {Sindhu, Nitika and Jain, Smita and Sharma, Swapnil and Paliwal, Swati},
title = {A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease},
journal = {ACS Chemical Neuroscience},
year = {2026},
doi = {10.1021/acschemneuro.6c00379}
}
EUVIMED